Loading clinical trials...
Loading clinical trials...
The major objective of this study is to evaluate the efficacy of the MACT versus the AMT for the treatment of large cartilage defects in patellofemoral and femorotibial injuries.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Centre Hospitalier Universitaire Vaudois
Collaborators
NCT06915233 · Chondral Defect, Articular Cartilage Defect
NCT03909139 · Acetabular Labrum Tear, Femoro Acetabular Impingement, and more
NCT06915363 · Knee Pain Chronic, Knee Osteoarthritis, and more
NCT04649905 · Osteochondritis Dissecans Knee, Psychological Stress
NCT03588975 · Chondral Defect, Osteochondritis Dissecans (OCD), and more
Hôpital Fribourgeois- HFR
Fribourg, Canton of Fribourg
Centre Hospitalier Universitaire Vaudois - CHUV
Lausanne, Canton of Vaud
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions